Michael J Kozal

Global HIV‐1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

A. Geretti, J. Llibre, S. Jacoby, 2015, HIV medicine.

Directly Administered Antiretroviral Therapy for HIV-Infected Drug Users Does Not Have an Impact on Antiretroviral Resistance: Results From a Randomized Controlled Trial

R. D. Bruce, M. Kozal, F. Altice, 2007, Journal of acquired immune deficiency syndromes.

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies

M. Kozal, M. Roberts, A. Justice, 2007, AIDS.

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.

B. Masquelier, A. Geretti, E. Svarovskaia, 2011, JAMA.